tesofensine and semaglutide together vs Semaglutide: A Guide to Weight Loss Medication Options ✨ TESOFENSINE – The Breakthrough

When it comes to the effect of GLP-1 analogues the reduction in postprandial glucose response, and insulinemia may actually contribute to weight loss, but also be the key drivers to the anti-diabetic effect and reduction in cardiovascular disease risks

Typical follow-up timing is 4 weeks after starting (to assess initial tolerance), then at dose increases, and every 3 months once stable

doi: 10.1136/bmj-2020-054370

The largest difference was seen for the endpoint 1.0% HbA1c reduction and 3.0% weight loss, where for each JPY 1 spent on semaglutide, spending of JPY 2.45 was required with dulaglutide to achieve an equivalent clinical outcome

13 Eligibility doesnt change because of having been pregnant